Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network

Murphy L, Gashi K, Kawamura J, Zhou C, Lynch D, Suskind D, Palermo T. Trajectory, risk factors, and impact of abdominal pain during the first year after pediatric IBD diagnosis: Results from the ImproveCareNow Network. NASPGHAN Annual Meeting, Chicago, IL 2019

Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system

Kandavel P, Adler J, Meister S. Reduction in corticosteroid usage among pediatric patients with inflammatory bowel disease in a large learning health system. NASPGHAN Annual Meeting, Chicago, IL 2019

Insurance status but not race determines sustained remission in pediatric IBD

Doan S, Jofriet A, Scott O, Riswan A, Venkateswaran S, Somineni H, Niklinska-Schirtz B, Talmadge C, Fritzen C, Dinser M, Dykes D, Gold B, Sauer C, Kugathasan S, Schoen B. Insurance status but not race determines sustained remission in pediatric IBD. NASPGHAN Annual Meeting, Chicago, IL 2019

Anemia prevalence in pediatrics IBD: Still persisted after 1 year

Malik P, Kim M, Puopolo G, Thompson J, Tomer G. Anemia prevalence in pediatrics IBD: Still persisted after 1 year. NASPGHAN Annual Meeting, Chicago, IL 2019

Hospitalizations in children with inflammatory bowel disease

Alper A, Algara M, Phatak U, Pashankar D. Hospitalizations in children with inflammatory bowel disease. NASPGHAN Annual Meeting, Chicago, IL 2019

Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018

Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018

Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. 13th Congress of European Crohn's and Colitis Organization, Vienna, February 2018

Treatment of pediatric Crohn's disease patients with early perianal complications

Adler J, Gadepalli S, Zacur G, Jarboe M, Dombkowski K. Treatment of pediatric Crohn's disease patients with early perianal complications. 2018 Crohn's & Colitis Congress, Las Vegas 2018

Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. ESPGHAN 51st Annual Meeting, Geneva 2018

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. ESPGHAN 51st Annual Meeting, Geneva 2018

Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. ESPGHAN 51st Annual Meeting, Geneva 2018

Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. ESPGHAN 51st Annual Meeting, Geneva 2018

Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry

Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. ESPGHAN 51st Annual Meeting, Geneva 2018

Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. Digestive Diseases Week 2018, Washington, DC  2018

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. Digestive Diseases Week 2018, Washington, DC 2018

Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network

Schaefer M, Nelson A, Sanchez R. Uveitis in a multicenter pediatric inflammatory bowel disease population: results from the Improvecarenow Network. Digestive Diseases Week 2018, Washington, DC 2018

Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice

Steiner S, Liu C, King E, Israel E, Pasternak B, Schaefer M, Chen S, Pratt J, Lazar A, Bereswill M, Robinson A, Colletti R, ImproveCareNow Network. Evaluation of adalimumab effectiveness in paediatric patients with Ulcerative Colitis in clinical practice. Digestive Diseases Week 2018, Washington, DC 2018

Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Patterns of use and durability of initial and sequential biological agents in a large paediatric inflammatory bowel disease observational cohort. Digestive Diseases Week 2018, Washington, DC 2018

Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort

Kaplan J, Liu C, King E, Bass J, Patel A, Tomer G, Tung J, Pratt J, Chen S, Lissoos T, Colletti R. Factors associated with discontinuation of initial and subsequent tumour necrosis factor inhibitors in a large paediatric inflammatory bowel disease observational cohort. Digestive Diseases Week 2018, Washington, DC 2018

Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry

Hensel K, Cunion D, Gasparetto M, Brennan M, Folan A, Lee C, Torrente F, Zilbauer M, Heuschkel R. Looking the truth in the eye-benchmarking cares and outcomes against the world's largest paediatric IBD registry. ESPGHAN 51st Annual Meeting, Geneva 2018

Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure

Gupta N, King E, Liu C, Sylvester F, Lee D, Boyle B, Trauernicht A, Chen S, Pratt J, Colletti R. Continued statural growth in older adolescents and young adults with Crohn's disease and ulcerative colitis beyond the time of expected growth plate closure. NASPGHAN Annual Meeting, Hollywood, FL 2018

Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease

Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Use of cannabis and opiates by adolescents and young adults with inflammatory bowel disease. NASPGHAN Annual Meeting, Hollywood, FL 2018

Outcomes in pediatric IBD patients not receiving immunological therapies

Benkov KJ, Serphos D. Outcomes in pediatric IBD patients not receiving immunological therapies. NASPGHAN Annual Meeting, Hollywood, FL 2018

Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. ESPGHAN 50th Annual Meeting, Prague, May 2017

Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements

Chadokufa S, Acton N, Sider S, Sheppard R, Wearon R, Shah N, Knaflez D, Kiparissi F. Successful use of the ImproveCareNow (ICN) quality improvement tool: Our 7-year outcomes and achievements. 4th Annual International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017

Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. 4th International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017

Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice

Steiner S, King E, Park KT, Pashankar D, Shashidhar H, Sudel B, Eichner S, Chen S, Pratt J, Colletti R. Evaluation of adalimumab effectiveness in anti-tumor necrosis factor-naïve pediatric patients with Crohn's disease in clinical practice. 12th Congress of European Crohn’s and Colitis Organization, Barcelona, September 2017

Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool

Chadokufa S, Wearon R. Outcomes from patient pre-visit planning (PVP) in Pediatric Inflammatory Bowel Disease (PIBD) using the ImproveCareNow (ICN) tool. 4th Annual International Symposium on Pediatric Inflammatory Bowel Disease, Barcelona, September 2017

Why and how adolescents and young adults with inflammatory bowel disease use cannabis

Hoffenberg E, Murphy B, Mikulich-Gilbertson S, McWilliams S, Hoffenberg A, Hopfer C. Why and how adolescents and young adults with inflammatory bowel disease use cannabis. NASPGHAN Annual Meeting, Las Vegas, November 2017

The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn’s disease

Benkov K, Russell G, Samson C, Steiner S, King EC, Pratt J, Eichner S, Colletti RB and the ImproveCareNow Network. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn’s disease.  11th Congress of European Crohn’s and Colitis Organization Congress, Amsterdam, March 2016

The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease

Benkov JK, Russell GH, Samson C, Steiner S, King E, Pratt J, Eichner S, Colletti RB. The use of concomitant immunomodulators with adalimumab therapy in pediatric Crohn's disease. ESPGHAN 49th Annual Meeting, Athens, Greece, May 2016

Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience

Lozinsky A, Kiparissi F, Huggett B, Chadokufa S, Sider S, Acton N, Baycheva M, Shah N. Efficacy and safety of co-therapy of biologics and methotrexate in a pediatric inflammatory bowel disease (pIBD) cohort: a single centre experience. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Montreal, October 2016

Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative

Adler J, Dong S, Dombkowski K. Prevention of perianal disease among pediatric patients with Crohn's disease in a pediatric inflammatory bowel disease quality improvement collaborative. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Montreal, October 2016

Providing timely and reliable care: a quality improvement initiative to improve follow-up visit rates in IBD patients

Prendaj E, Thomas S, Tomer G. Providing timely and reliable care: a quality improvement initiative to improve follow-up visit rates in IBD patients. World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Montreal, October 2016

Implementing transition of care and transfer of care systems in pediatric IBD

Schaefer M, Tung J, Maddux M, Kim S. Implementing transition of care and transfer of care systems in pediatric IBD. Advances in IBD, Orlando, December 2016

Data on surgery in paediatric IBD (pIBD) over a 4-year period using the ImproveCareNow (ICN) collaboration data base

S Sider, S Chadokufa, B Huggett, N Shah, M Elawad, F Kiparissi. Data on surgery in paediatric IBD (pIBD) over a 4-year period using the ImproveCareNow (ICN) collaboration data base. 10th Congress of European Crohn's and Colitis Organization, Barcelona, Spain, February 2015

Improvement of patient's disease activity in paediatric inflammatory bowel disease (pIBD) after adoption of ImproveCareNow (ICN) quality improvement (QI) tool

B Huggett, S Chadokufa, S Sider, T Sawney, N Shah, M Elawad, F Kiparissi . Improvement of patient's disease activity in paediatric inflammatory bowel disease (pIBD) after adoption of ImproveCareNow (ICN) quality improvement (QI) tool. 10th Congress of European Crohn's and Colitis Organization, Barcelona, Spain, February 2015

Achieving remission in paediatric inflammatory bowel disease (pIBD): Data on mono- vs. combination therapy using the ImproveCareNow (ICN) data base

S Chadokufa, B Huggett, S Sider, N Shah, M Elawad, F Kiparissi. Achieving remission in paediatric inflammatory bowel disease (pIBD): Data on mono- vs. combination therapy using the ImproveCareNow (ICN) data base. 10th Congress of European Crohn's and Colitis Organization, Barcelona, Spain, February 2015

Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry

Adler J, Dong S, Dombkowski K. Identifying fistulizing Crohn's disease in a national pediatric inflammatory bowel disease quality improvement collaborative registry. Poster presentation, Digestive Diseases Week, Washington DC, May 2015

Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network

Dotson J, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial differences in initial presentation and early treatment of pediatric Crohn's disease - preliminary results from the ImproveCareNow Network. Oral presentation, Digestive Diseases Week, Washington DC, May 2015

Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network

Adler J, Grossman A, Israel EJ, Kim S, Saeed SA, Pratt JM, Collins J, Colletti RB, ImproveCareNow Network. Extent of disease in ulcerative colitis in a pediatric inflammatory bowel disease learning health network. Poster presentation at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Washington DC, October 2015 

Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life

Adler J, Saeed S, Thakkar S, Eslick I, Margolis P, Provost L, Kaplan H. Feasibility of a mobile personalized learning system for assessing daily IBD symptoms and quality of life. Poster presentation, Advances in IBD, Orlando, December 2015

Racial Differences in Initial Presentation, Early Treatment, and 1-Year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network

Dotson J, Cho M, Bricker J, Kappelman M, Chisolm D, Tomer G, Crandall W. Racial Differences in Initial Presentation, Early Treatment, and 1-Year Outcomes of Pediatric Crohn's Disease: Results from the ImproveCareNow Network. Poster presentation, Advances in IBD, Orlando, December 2015

A continuous state of beta: designing and implementing a learning exchange for chronic care

McLinden D, Myers SK. A continuous state of beta: designing and implementing a learning exchange for chronic care. Academy of Healthcare Improvement, March 2014

Healthier together: using a multimedia communication campaign and improvement science to build patient engagement in a learning health system

Opipari L, Margolis PA, Nocito S, Morgan P, Seid M. Healthier together: using a multimedia communication campaign and improvement science to build patient engagement in a learning health system. Academy of Healthcare Improvement, March 2014

Innovation insights from dynamic social network analysis in a digitally-enabled collaborative chronic care network

Provost S, McKean M, Grippa F, Thakkar S, Seid M, McDaniel R, Gloor P, Margolis PA. Innovation insights from dynamic social network analysis in a digitally-enabled collaborative chronic care network. Academy of Healthcare Improvement, March 2014

Section on Hospital Medicine Program "Collaborative Guideline Implementation & Learning"

Margolis PA. Section on Hospital Medicine Program "Collaborative Guideline Implementation & Learning". American Academy of Pediatrics National Conference & Exhibition, San Diego, CA, October 2014

Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease

Kappelman MD, Bailey LC, Crandall WV, Zhang P, King E, Joffe M, Colletti RB, Forrest, CB and the ImproveCareNow Network. Real-world clinical and comparative effectiveness of infliximab in pediatric Crohn’s disease. Oral presentation, Digestive Diseases Week, Orlando FL, May 2013

Use of the emergency department in pediatric inflammatory bowel disease

Hoffenberg EJ, Fridge J, Leibowitz I, Tsou M, Dykes D, Kappelman M, Colletti R. Use of the emergency department in pediatric inflammatory bowel disease. Poster presentation, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Chicago, October 2013

Creating the ImproveCareNow Learning Health System

Crandall WV, Margolis PA, Moon T, Colletti RB. Creating the ImproveCareNow Learning Health System. Learning Lab, Institute for Healthcare Improvement Forum, Orlando, December 2013

Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice

Dotson JL, Crandall WV, Zhang P, Forrest CB, Bailey CJ, Colletti RB, Kappelman MD. Feasibility and validity of the pediatric ulcerative colitis activity index in routine clinical practice. Oral presentation, Advances in IBD Conference, Hollywood FL, December 2013

Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease?

Burkam J, Kappelman M, King E, Pratt J, Colletti R, Bistrick S, Crandall W.  Is there seasonal variation of disease activity in pediatric-onset inflammatory bowel disease? Oral presentation, Digestive Diseases Week, San Diego CA, May 2012

Increased remission in a quality improvement collaborative for pediatric Crohn’s disease

Colletti RB, Crandall W, Kappelman M, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Milov D, King E, Pratt J, Margolis P, and the ImproveCareNow Collaborative. Increased remission in a quality improvement collaborative for pediatric Crohn’s disease.  Poster presentation at the International Forum on Quality and Safety in Healthcare, Amsterdam, The Netherlands, April 2011

Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease?

Lee G, Kappelman MD, Boyle B, Colletti RB, King E, Pratt J, Crandall W.  Are there gender differences in the clinical outcomes of pediatric inflammatory bowel disease?  Oral presentation, Digestive Diseases Week, Chicago IL, May 2011

Improved outcomes in a quality improvement collaborative for pediatric ulcerative colitis

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Improved outcomes in a quality improvement collaborative for pediatric ulcerative colitis.  Oral presentation, Digestive Diseases Week, New Orleans, May 2010

Towards growing a COIN in a medical research community

Gloor PA, Grippa F, Margolis P, Seid M, Colletti R, Borgert A, Dellal G. Towards growing a COIN in a medical research community. Collaborative Innovation Conference, Savannah GA, September 2010

Quality Improvement in Pediatric Inflammatory Bowel Disease

Margolis PA, Kappelman MD, Crandall WV, Baron HI, Morgan P, Duffy L, Colletti RB. Quality Improvement in Pediatric Inflammatory Bowel Disease. Oral symposium presentations, Postgraduate Course, North American Society for Pediatric Gastroenterology Hepatology and Nutrition, New Orleans, October 2010

Increased remission in a quality improvement collaborative for pediatric Crohn disease

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Increased remission in a quality improvement collaborative for pediatric Crohn disease.  Poster presentation, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, National Harbor, MD, November 2009

A rapid pediatric Crohn's disease activity index for quality improvement and observational research

Kappelman, M, Goudie, A. Crandall, W, Larry, E, Fairbrother, G, Margolis, P, Leibowitz, I, Duffy, L, Milov, D, Kim, S, Schoen, B, Cohen, S, Patel, A, Grunow, J, Colletti, R, and the ImproveCareNow Collaborative (formerly PIBDNet). A rapid pediatric Crohn's disease activity index for quality improvement and observational research. Poster presentation, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, National Harbor, MD, November 2009

Improved outcomes in a quality improvement collaborative for pediatric Crohn disease

Crandall W, Kappelman M, Colletti RB, Denson L, Duffy L, Grunow J, Kim S, Leibowitz I, Patel A, Schoen B, Tomer G, Milov D, Cohen S, Margolis P, and the ImproveCareNow Collaborative (formerly PIBDNet). Improved outcomes in a quality improvement collaborative for pediatric Crohn disease.  Oral presentation, Advances in IBD Conference, Hollywood, FL, December 2009



Improving care of pediatric inflammatory bowel disease: preliminary results of a multicenter improvement collaborative

Kappelman MD, Cohen SA, Crandall W, Duffy L, Gold BD, Grunow J, Kim SC, Leibowitz I, Margolis PA, Mehta DI, Milov DE, Moyer MS, Myers S, Patel AS, Schoen B, Sudel B, Bornstein JA, Colletti RB.  Improving care of pediatric inflammatory bowel disease: preliminary results of a multicenter improvement collaborative.  Poster presentation at the Pediatric Academic Societies Annual Meeting, Honolulu HI, May 2008

Accelerating improvement in the management of pediatric inflammatory bowel disease

Kappelman MD, Cohen SA, Crandall W, Duffy LF, Gold BD, Grunow J, Kim SC, Leibowitz I, Margolis P, Mehta DI, Milov DE, Moyer MS, Myers SK, Patel AS, Schoen BT, Sudel B, Colletti RB.  Accelerating improvement in the management of pediatric inflammatory bowel disease.  Poster presentation at Digestive Diseases Week, San Diego CA, May 2008

Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotypeGrowth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype

Patel AS, Kim S, Kappelman M, Colletti R, Cohen S, Grunow J, Crandall W, Duffy L, Gold B, Leibowitz I, Margolis P, Mehta D, Milov D, Moyer S, Myers S, Schoen B, Sudel B, Bornstein J. Growth failure in a pediatric inflammatory bowel disease registry (PIBDNet) with specific association to disease phenotype.  Poster presentation at the 3rd World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, Iguassu Falls, Brazil, August 2008

 

The quality of care in pediatric inflammatory bowel disease: does the chronic care model work?

Kappelman M, Margolis P, Moyer M, Cohen S, Gold B, Crandall W, Patel A, Mehta D, Milov D, Grunow J, Leibowitz I, Colletti R.  The quality of care in pediatric inflammatory bowel disease: does the chronic care model work?  Poster presentation, North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Salt Lake City, Utah, October 2007

Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease

Colletti RB, Baldassano RN, Milov DE, Margolis PA, PIBDNet –the Pediatric IBD Network for Research and Improvement.  Variation in initial 6-mercaptopurine dosage in pediatric Crohn's disease.  Poster presentation, Digestive Diseases Week, Los Angeles, CA, May 2006

Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine

Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement.  Predictors of outcome of treatment of pediatric Crohn’s disease with 6-mercaptopurine or azathioprine.  Poster presentation at the First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy, November 2006

Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care

Colletti RB, Baldassano RN, Milov DE, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Initial dosage of 6-mercaptopurine in pediatric Crohn’s disease: a study of variation in care.  Poster presentation at the First International Symposium on Pediatric Inflammatory Bowel Disease, Rome, Italy, November 2006

PIBDNet—the Pediatric IBD Network for Research Improvement: First steps towards a great leap

Colletti RB.  PIBDNet—the Pediatric IBD Network for Research Improvement: First steps towards a great leap.  Plenary session presentation at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Salt Lake City, UT, October 2005

Variation in initial evaluation and treatment of pediatric Crohn disease

Colletti R, Baldassano R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement.  Variation in initial evaluation and treatment of pediatric Crohn disease.  Poster presentation at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Salt Lake City, UT, October 2005

Variation in initial 6-mercaptopurine dosage in Crohn disease

Baldassano R, Colletti R, Milov D, Margolis P, for PIBDNet—the Pediatric IBD Network for Research and Improvement. Variation in initial 6-mercaptopurine dosage in Crohn disease.  Poster presentation at the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition Annual Meeting, Salt Lake City, UT, October 2005

 

Built by Veracity Media on NationBuilder